ITALIAN-FRENCH INTERNATIONAL CONFERENCE ON MAGNETIC RESONANCE

Last updated Jul 11, 2024

The conference will aim to present advanced developments and applications of Magnetic Resonance (MR) in different fields crucial for human health, sustainability, and technology.

The Future of Regulatory Compliance: What to Watch for in…

Sep 30, 2025

What’s New in Dental Billing and Coding for 2025

May 30, 2025

Developing Prefrontal Circuits and Their Role in Health and…

May 17, 2024

The Future of Regulatory Compliance: What to Watch for in…

Sep 30, 2025

What’s New in Dental Billing and Coding for 2025

May 30, 2025

Developing Prefrontal Circuits and Their Role in Health and…

May 17, 2024

Post Views: 653

Startups in the healthcare IT space are now too eager to accept pilot status.

Finding Relief: Effective Head Cure for Migraines

Leave A Reply

Articles

Sequana Medical announces results of Annual General Meeting of Shareholders

2026-05-28T19:00:00Z

Ghent, Belgium, May 28, 2026 (GLOBE NEWSWIRE) -- PRESS RELEASE | REGULATED INFORMATION | 28 May 2026, 9:00 pm CEST

Aclarion, Inc. Comments on Echo Lake Capital’s Letter and Unsolicited Proposal

2026-05-28T18:49:24Z

BROOMFIELD, Colo., May 28, 2026 (GLOBE NEWSWIRE) -- Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI)...

Guidepoint Qsight Launches Medical Aesthetics Patient Journey Analytics Product

2026-05-28T18:37:09Z

New York, NY, USA, May 28, 2026 (GLOBE NEWSWIRE) -- New Dashboard Provides Data-Driven Insights on Treatment Pairings and Cross-Purchasing Over Time

Hospital Bed Solutions by Prosperity Health Releases Industry Report on Rising Aging-in-Place Demand Across New England

2026-05-28T18:30:00Z

As more seniors choose to age in place, Hospital Bed Solutions, a Prosperity Health brand, says hospital beds, mobility equipment, and respiratory support are becoming essential tools for home-based care.

Bay Area Lyme Foundation Raises $900,000 at LymeAid 2026, Presenting Inaugural Neil L. Spector, MD, Legacy Award and $300,000 in Emerging Leader Grants

2026-05-28T18:00:00Z

Dana Carvey Emceed; Chris Isaak Performed at Annual Gala Advancing Lyme and Tick-Borne Disease Research

Medx Holdings (MEDH) Announces Landmark Submission for DEA Registration Through Lazydaze ABQ LLC, Joining an Elite Group of Public Companies Pioneering Federal Medical Cannabis Access

2026-05-28T17:34:23Z

Medx Holdings Submits DEA Registration in a Major Push to Normalize the Medical Cannabis Lifestyle

Tevogen Advances Strategic Acquisition Initiatives with Potential to Support Approximately $100 Million in Combined Annual Revenue

2026-05-28T16:30:00Z

WARREN, N.J., May 28, 2026 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN) today announced continued progress across its strategic acquisition initiatives intended to complement its...

New research reveals COVID-19's long-term impact on kids

2026-05-28T16:00:56Z

Washington, DC, May 28, 2026 (GLOBE NEWSWIRE) -- New research from Children’s National Hospital and the National Institutes of Health (NIH) is offering one of the most comprehensive insights yet into...

Valneva to Participate at U.S. and European Investor Conferences in June

2026-05-28T15:45:00Z

Lyon (France), May 28, 2026 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that its senior management will present and hold investor meetings at...

Clue Becomes the First Insurance-Covered Period and Menstrual Cycle Tracker in the World

2026-05-28T15:34:22Z

BERLIN, May 28, 2026 (GLOBE NEWSWIRE) -- Clue, the #1 women-led period and cycle tracker, today announced a partnership with Süddeutsche Krankenversicherung a. G. (SDK), one of Germany’s leading private...

H1 Receives $40M Investment in Round Led by CVS Health Ventures

2026-05-28T15:00:00Z

H1 helps healthcare players transform operations with AI

Pemvidutide Demonstrates Significant Metabolic Improvements in Patients with MASH in New 48‑Week IMPACT Phase 2b Data Presented at EASL 2026

2026-05-28T15:00:00Z

“Best of EASL” oral presentation highlights meaningful reductions in triglycerides, cholesterol, and blood pressure, along with improvements in key metabolic risk factors

RadioMedix to Present at SNMMI 2026 and Mark 20 Years of Radiopharmaceutical Innovation

2026-05-28T14:42:30Z

Company’s SNMMI week activities highlight scientific progress and two decades of advancing precision nuclear medicine for patients with hard-to-treat cancers

Pharming Group announces results of 2026 Annual General Meeting of Shareholders

2026-05-28T14:40:00Z

Leiden, the Netherlands, May 28, 2026: Pharming Group (“Pharming” or “the Company”) (Euronext Amsterdam: PHARM / Nasdaq: PHAR) today announced that shareholders approved all proposals presented at its Annual General Meeting...

Fortis Life Sciences Expands AbNano® Portfolio with First VHH Library Derived from Peripheral Natural Killer Cells for Rapid Antibody Discovery

2026-05-28T14:33:00Z

The new AbNano® library enables VHH discovery against complex NK-cell-associated targets for engineered cell platforms and translational research

ProMIS Neurosciences to Participate in Upcoming Conferences in June

2026-05-28T14:13:28Z

CAMBRIDGE, Mass., May 28, 2026 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (Nasdaq: PMN), a clinical-stage biotechnology company developing antibody therapeutics and vaccines targeting toxic misfolded proteins in neurodegenerative diseases, today...

Serotonin Centers Opens in Lake Nona, Expanding Physician-Led Longevity Care into One of the Nation’s Leading Health Innovation Communities

2026-05-28T13:39:00Z

New Location Aligns with Growing Demand for Data-Driven Wellness, Hormone Optimization and Advanced Recovery Therapies

MMI Earns Gold Edison Award for Symani®, Recognized for Expanding Access to Life-Changing Surgical Treatment Options

2026-05-28T13:30:00Z

Symani honored for advancing lymphatic microsurgery – from treating lymphedema to enabling exploration of new disease pathways

Menarini Group Presents New Data from the Phase 1b/2 ELEVATE Study of Elacestrant (ORSERDU®) in Combination with Capivasertib in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting

2026-05-28T13:30:00Z

FLORENCE, Italy and NEW YORK, May 28, 2026 (GLOBE NEWSWIRE) -- The Menarini Group (“Menarini”), a leading international pharmaceutical and diagnostics company, and Stemline Therapeutics, Inc. (“Stemline”), a wholly-owned subsidiary...

Akari Therapeutics Discusses Breakthrough Potential of AKTX-101 and Novel Spliceosome-Modulating ADC Platform in Virtual Investor “What This Means” Segment Following ASCO Abstract Acceptance

2026-05-28T13:17:00Z

CEO Abizer Gaslightwala highlights promising ASCO data demonstrating synergy of AKTX-101 with adagasrib in KRAS-driven cancers

Range Impact Announces West Virginia Attorney and Business Advisor Michael Simon Has Joined the Company as a Strategic Advisor

2026-05-28T13:15:00Z

CLEVELAND, OHIO, May 28, 2026 (GLOBE NEWSWIRE) -- Range Impact, Inc. (OTC: RNGE) (“Range Impact” or the “Company”), a public company dedicated to acquiring, reclaiming and repurposing distressed coal mine...